Independent Advisor Alliance grew its stake in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 4.3% in the 4th quarter, ...

The average brokerage recommendation (ABR) for Veeva (VEEV) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after ...

Veeva Systems has an accrual ratio of -0.55 for the year to January 2025. That indicates that its free cash flow quite significantly exceeded its statutory profit. In fact, it had free cash flow ...

Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The ...

Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid fourth-quarter fiscal 2025 performance and ...

Whether you're a growth, value, income, or momentum-focused investor, building a successful investment portfolio takes skill, research, and a little bit of luck. But how do you find the right ...

Institutional support and a healthy fundamental backdrop make this company worth investigating. As you can see, VEEV has had strong sales and earnings growth: Also, EPS is estimated to ramp higher ...

PLEASANTON, CA – Veeva Systems Inc. (NYSE:VEEV), a leader in cloud-based software for the global life sciences industry with a market capitalization of $38 billion, announced the upcoming ...

Boehringer Ingelheim and Veeva Systems have announced the launch of Boehringer’s One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They ...

Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...